About
- Overview
  We advance the field of genomic science by leveraging our key strengths.
- Our People
  Each individual brings unique expertise to the NYGC’s team of innovators.
- Contact Us
  Contact us with general inquiries or for more information.
  - NYGC Team Login
Science & Technology
- Collaborative Research Programs
  We work with leading medical and academic institutions in New York and beyond.
- Faculty Labs
  Dive into the profiles of our faculty members and learn about their research.
- Technology Platforms
  Our advanced technology platforms provide essential tools for researchers.
Clinical Genetics
Collaborate
- Affiliate Membership Program
  The Affiliate Membership Program allows external academic researchers to collaborate with NYGC, contributing to and benefiting from its genomic research initiatives.
- Scientific Collaboration & Project Management
  The Project Management team works across disciplines and institutions with partners in academia, industry, private foundations, and large consortia to bring the promise of genomics to bear on biomedical research.
  - Research Administration
  - Research Sequencing
- Tech Transfer
  Our dedicated technology transfer personnel identify research results with potential commercial interest.
Publications
Careers
- Our Culture & Values
  The NYGC’s core values of collaboration, innovation, integrity, and community engagement are reflected in all aspects of our work.
  - Benefits
- Open Positions & Training Opportunities
  Join us on our mission to advance genomic science and its application to novel biomedical discoveries.
News & Events
- News
  Access press releases, research updates, and feature articles.
  - Press Room
- Events
  Discover exciting events, including seminars, workshops, webinars, and conferences.
  - Past Events

About Us > Our People > Board of Directors > Rory Riggs

Rory Riggs

Board Member, NYGC Co-founder and Chairman of Cibus

Rory Riggs is a co-founder and chairman of Cibus; CEO & founder of Locus Analytics LLC and Syntax LLC; chairman and co-founder of Royalty Pharma, the largest investor in revenue producing intellectual property (principally royalty interests in marketed and late stage development biopharmaceutical products); and co-founder and board member of Fibrogen. He was a board member of Intra-Cellular Therapies and was the former president and board member of Biomatrix, Inc that developed and launched Synvisc® an intra-articular injection for osteoarthritis. He is a co-founder, general partner of Scientia Ventures.

Mr. Riggs received an MBA from Columbia University and a Bachelor of Arts from Middlebury College.